The study examined long-term therapy persistence with glatiramer acetate relative to other available disease-modifying therapies for multiple sclerosis.

Retrospective US Database Analysis of Persistence With Glatiramer Acetate vs. Available Disease-Modifying Therapies for Multiple Sclerosis: 2001–2010 ...

Zydus’ generic Glatiramer Acetate Injection is an FDA-approved, AP-rated substitutable generics of Copaxone ® 20 mg/ml, 40 mg/ml and indicated for the treatment of relapsing forms of Multiple ...

US Food and Drug Administration. FDA adds Boxed Warning about a rare but serious allergic reaction called anaphylaxis with the multiple sclerosis medicine glatiramer acetate (Copaxone, Glatopa).

If someone with multiple sclerosis experiences any symptoms of anaphylaxis after taking glatiramer acetate, they should seek immediate medical attention by going to an emergency room or calling ...

Glatiramer acetate (Copaxone) is considered part of the “platform therapy” for MS. It’s also among the earliest approved disease-modifying treatments.

Patients should stop taking glatiramer acetate and seek immediate medical attention by going to an emergency room or calling 911 if you experience symptoms of an anaphylactic reaction, FDA warned.

FDA issues new warnings about rare but severe allergic reactions, including anaphylaxis, linked to MS drug glatiramer acetate, urging immediate medical attention.

The US Food and Drug Administration (FDA) is adding the risk of anaphylaxis to a new boxed warning of glatiramer acetate, a medicine for multiple sclerosis (MS). The agency issued the warning ...

The US Food and Drug Administration (FDA) is adding the risk of anaphylaxis to a new boxed warning of glatiramer acetate, a medicine for multiple sclerosis (MS). The agency issued the warning about ...

The drug, glatiramer acetate, is approved to treat patients with relapsing forms of multiple sclerosis, a chronic disease that affects the central nervous system.

Today, the FDA issued a warning about the risk of anaphylaxis, a rare but life-threatening allergic reaction, linked to certain multiple sclerosis (MS) drugs, including glatiramer acetate ...